Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rosenfeld Jeffrey, MD
Carolinas ALS Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
- University of Kansas
Kansas City, Kansas, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- University of Texas Health Science Center
San Antonio, Texas, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2003
- Primary completion
- —
- Completion
- 30 Apr 2005
- Last update posted
- 24 Jun 2005
- Registered enrollment
- 107
- Registry id
- NCT00069186
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.